Vyome Holdings (HIND) Inventory Average (2016 - 2025)
Vyome Holdings (HIND) posted quarterly Inventory Average of $2.5 million for Q2 2025, down 24.27% year-over-year from $3.4 million in Q2 2024, and up 1.84% quarter-over-quarter from $2.5 million in Q1 2025.
Vyome Holdings (HIND) Inventory Average (2016 - 2025) Analysis & Trends
Vyome Holdings' Inventory Average history runs 10 years deep, the most recent figure standing at $2.5 million for Q2 2025.
- In Q2 2025, Inventory Average fell 24.27% year-over-year to $2.5 million; the TTM figure through Jun 2025 stood at $2.5 million (down 24.27% YoY), while the FY2024 annual figure was $3.1 million, down 15.66% from the prior year.
- Inventory Average for Q2 2025 stood at $2.5 million, up from $2.5 million in the prior quarter.
- The five-year high for Inventory Average was $4.2 million in Q3 2022, with the low at $2.5 million in Q1 2025.
- The 5-year median for Inventory Average is $3.4 million (2023), against an average of $3.3 million.
- The sharpest annual moves came in 2022 and 2025: Inventory Average surged 37.66% in 2022, then slumped 30.74% in 2025.
- Vyome Holdings' Inventory Average stood at $3.1 million in 2021, then advanced by 25.33% to $3.9 million in 2022, then decreased by 10.76% to $3.5 million in 2023, then declined by 22.33% to $2.7 million in 2024, then decreased by 5.75% to $2.5 million in 2025.
- Business Quant data shows HIND's Inventory Average at $2.5 million in Q2 2025, $2.5 million in Q1 2025, and $2.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 3.89 Mn |
| Sep 30, 2022 | 4.20 Mn |
| Jun 30, 2022 | 4.11 Mn |
| Mar 31, 2022 | 3.50 Mn |
| Dec 31, 2021 | 3.10 Mn |
| Sep 30, 2021 | 3.05 Mn |
| Mar 31, 2020 | 1.67 Mn |
| Dec 31, 2019 | 1.99 Mn |
| Sep 30, 2019 | 2.08 Mn |
| Jun 30, 2019 | 1.98 Mn |